Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trial

Franck Boralevi, Guillaume Simon, Charlotte Bernigaud, Jennifer Brun, Elisa Goujon, Jean-Luc Perrot, Alice Phan, Anne-Laure Hérissé, Annabel Maruani, Clélia Vanhaecke, Emmanuelle Couty, Claire Abasq-Thomas, Marine Fournet, Stéphanie Mallet, Emilie Brenaut, Thomas Hubiche, Xavier Balguerie, Frédéric Caux, Nathalie Beneton, Anne-Sophie Dutkiewicz, Henri Adamski, Hélène Aubert, Emmanuelle Bourrat, Caroline Couzan, Alexia Eyraud, Raphaël Janela-Lapert, Aurélie Marti, Juliette Miquel, Muriel Richard, Sébastien Barbarot, Bertille Bonniaud, Cécile Chabbert, Frédérique Delion, Monica Dinulescu, Tu-Anh Duong, Maxime Etienne, Gaëlle Hirsch, Camille Isnard, Flavien Huet, Emmanuelle Le Bidre, Sophie Leducq, Adeline Legrand, Sandrine Monestier, Fanny Morice-Picard, Julien Seneschal, Aurore Capelli, Caroline Lacoste, Christine Labrèze, Giulio Miraglia, Giao Do-Pham, Bruno Giraudeau, Olivier Chosidow

Open source

DOI
10.1136/bmj-2025-086277
Published
2026-01-06
Container
BMJ
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmj-2025-086277,
  title = {Oral ivermectin versus 5\% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trial},
  author = {Franck Boralevi and Guillaume Simon and Charlotte Bernigaud and Jennifer Brun and Elisa Goujon and Jean-Luc Perrot and Alice Phan and Anne-Laure Hérissé and Annabel Maruani and Clélia Vanhaecke and Emmanuelle Couty and Claire Abasq-Thomas and Marine Fournet and Stéphanie Mallet and Emilie Brenaut and Thomas Hubiche and Xavier Balguerie and Frédéric Caux and Nathalie Beneton and Anne-Sophie Dutkiewicz and Henri Adamski and Hélène Aubert and Emmanuelle Bourrat and Caroline Couzan and Alexia Eyraud and Raphaël Janela-Lapert and Aurélie Marti and Juliette Miquel and Muriel Richard and Sébastien Barbarot and Bertille Bonniaud and Cécile Chabbert and Frédérique Delion and Monica Dinulescu and Tu-Anh Duong and Maxime Etienne and Gaëlle Hirsch and Camille Isnard and Flavien Huet and Emmanuelle Le Bidre and Sophie Leducq and Adeline Legrand and Sandrine Monestier and Fanny Morice-Picard and Julien Seneschal and Aurore Capelli and Caroline Lacoste and Christine Labrèze and Giulio Miraglia and Giao Do-Pham and Bruno Giraudeau and Olivier Chosidow},
  year = {2026},
  journal = {BMJ},
  doi = {10.1136/bmj-2025-086277},
  url = {https://doi.org/10.1136/bmj-2025-086277}
}

RIS

TY  - JOUR
TI  - Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trial
AU  - Franck Boralevi
AU  - Guillaume Simon
AU  - Charlotte Bernigaud
AU  - Jennifer Brun
AU  - Elisa Goujon
AU  - Jean-Luc Perrot
AU  - Alice Phan
AU  - Anne-Laure Hérissé
AU  - Annabel Maruani
AU  - Clélia Vanhaecke
AU  - Emmanuelle Couty
AU  - Claire Abasq-Thomas
AU  - Marine Fournet
AU  - Stéphanie Mallet
AU  - Emilie Brenaut
AU  - Thomas Hubiche
AU  - Xavier Balguerie
AU  - Frédéric Caux
AU  - Nathalie Beneton
AU  - Anne-Sophie Dutkiewicz
AU  - Henri Adamski
AU  - Hélène Aubert
AU  - Emmanuelle Bourrat
AU  - Caroline Couzan
AU  - Alexia Eyraud
AU  - Raphaël Janela-Lapert
AU  - Aurélie Marti
AU  - Juliette Miquel
AU  - Muriel Richard
AU  - Sébastien Barbarot
AU  - Bertille Bonniaud
AU  - Cécile Chabbert
AU  - Frédérique Delion
AU  - Monica Dinulescu
AU  - Tu-Anh Duong
AU  - Maxime Etienne
AU  - Gaëlle Hirsch
AU  - Camille Isnard
AU  - Flavien Huet
AU  - Emmanuelle Le Bidre
AU  - Sophie Leducq
AU  - Adeline Legrand
AU  - Sandrine Monestier
AU  - Fanny Morice-Picard
AU  - Julien Seneschal
AU  - Aurore Capelli
AU  - Caroline Lacoste
AU  - Christine Labrèze
AU  - Giulio Miraglia
AU  - Giao Do-Pham
AU  - Bruno Giraudeau
AU  - Olivier Chosidow
PY  - 2026
JO  - BMJ
DO  - 10.1136/bmj-2025-086277
UR  - https://doi.org/10.1136/bmj-2025-086277
ER  - 

APA

Boralevi, F., Simon, G., Bernigaud, C., Brun, J., Goujon, E., Perrot, J., Phan, A., Hérissé, A., Maruani, A., Vanhaecke, C., Couty, E., Abasq-Thomas, C., Fournet, M., Mallet, S., Brenaut, E., Hubiche, T., Balguerie, X., Caux, F., Beneton, N., Dutkiewicz, A., Adamski, H., Aubert, H., Bourrat, E., Couzan, C., Eyraud, A., Janela-Lapert, R., Marti, A., Miquel, J., Richard, M., Barbarot, S., Bonniaud, B., Chabbert, C., Delion, F., Dinulescu, M., Duong, T., Etienne, M., Hirsch, G., Isnard, C., Huet, F., Bidre, E. L., Leducq, S., Legrand, A., Monestier, S., Morice-Picard, F., Seneschal, J., Capelli, A., Lacoste, C., Labrèze, C., Miraglia, G., Do-Pham, G., Giraudeau, B., & Chosidow, O. (2026). Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trial. BMJ. https://doi.org/10.1136/bmj-2025-086277

Source records